C1 ESTERASE INHIBITOR TO REDUCE MIOCARD INJURY DURING AN ACUTE MIOCARD INFRATEMENT.

摘要

A METHOD OF THERAPEUTIC OR PROFILACTIC TREATMENT OF ACUTE MIOCARDIC INFARTATION, WHICH CONSISTS IN ADMINISTERING AN INHIBITOR OF THE STERASE C1 EXOGENOUS, ONLY OR COMBINED WITH OTHER PHARMACOS, TO A PATIENT WITH MIOCARDIC INFRINGED INFRINGEMENT OF ACUTE MYOCARDIUM. THE TREATMENT INHIBITATES THE INFLAMMATORY REACTION, AND MORE SPECIFICALLY THE ACTIVATION OF THE COMPLEMENTARY SYSTEM, WHICH HAS A PLACE DURING AN ACUTE MIOCARDIC INFRINGEMENT. THE ESTERASA C1 INHIBITOR MAY INCLUDE A PURIFIED C1 ESTERASE INHIBITOR FROM A PLASMA OR OTHER BIOLOGICAL MATERIALS, OR A RECOMBINANT C1 ESTERASE INHIBITOR, OR RECOMBINATING STRUCTURES FROM OTHER INHIBITING THAN INHIBITING THE OTHER OF THE ESTERASE C1.